{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:46:17Z","timestamp":1782607577883,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jvoice.2021.01.012","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T07:22:26Z","timestamp":1613373746000},"page":"471.e7-471.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Laryngeal Pemphigoid Evolution and Response to Treatment"],"prefix":"10.1016","volume":"37","author":[{"given":"Shira","family":"Barmatz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avital","family":"Baniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Eremenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narin Nard Carmel","family":"Neiderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oshri","family":"Wasserzug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Sprecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Oestreicher-Kedem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2021.01.012_bib0001","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4172\/2161-119X.1000206","article-title":"Bullous lesion of larynx? an airway emergency","volume":"5","author":"Vivek Abraham","year":"2015","journal-title":"Otolaryngology"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0002","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/archderm.1990.01670330121028","article-title":"ory bullous pemphigoid leading to respiratory arrest and successfully treated with plasmapheresis","volume":"126","author":"Konstadt","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0003","first-page":"E1","article-title":"Features of oral, pharyngeal, and laryngeal lesions in bullous pemphigoid","volume":"95","author":"Ohki","year":"2016","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0004","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/000348940311200314","article-title":"Cicatricial pemphigoid in the upper aerodigestive tract: diagnosis and management in severe laryngeal stenosis","volume":"112","author":"Boedeker","year":"2003","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0005","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0006","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5144\/0256-4947.2006.152","article-title":"Laryngeal involvement in a patient with bullous pemphigoid","volume":"26","author":"Iqbal","year":"2006","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0007","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/coa.12676","article-title":"ent and management of laryngeal mucous membrane pemphigoid: our experience in six patients and a proposed severity scale","volume":"42","author":"Nash","year":"2016","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0008","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jvoice.2017.03.025","article-title":"Epiglottitis as the presenting sign of mucous membranous pemphigoid: A case report","volume":"32","author":"Carmel-Neiderman","year":"2018","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0009","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/den.12893","article-title":"Endoscopic findings of laryngopharyngeal and esophageal involvement in autoimmune bullous disease","volume":"29","author":"Nakamura","year":"2017","journal-title":"Digestive Endoscopy"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0010","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jama.284.3.350","article-title":"Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations","volume":"284","author":"Yancey","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0011","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clindermatol.2011.03.015","article-title":"Treatment of subepidermal immunobullous diseases","volume":"30","author":"Culton","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0012","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.det.2011.03.010","article-title":"Clinical features and practical diagnosis of bullous pemphigoid","volume":"29","author":"Schmidt","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0013","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40257-017-0264-2","article-title":"Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment","volume":"18","author":"Bernard","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0014","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/jamadermatol.2018.5049","article-title":"Assessment of the Prevalence of Mucosal Involvement in Bullous Pemphigoid","volume":"155","author":"Kridin","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-4362.1986.tb04544.x","article-title":"Cicatricial pemphigoid","volume":"25","author":"Ahmed","year":"1986","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0016","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00405-020-05812-3","article-title":"Mucous membrane pemphigoid\u2013otorhinolaryngological manifestations: a retrospective cohort study","volume":"277","author":"Madgar","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0017","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0018","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaad.2014.08.024","article-title":"Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts","volume":"72","author":"Murrell","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0019","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2000.107248","article-title":"Cicatricial pemphigoid","volume":"43","author":"Fleming","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0020","first-page":"370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan, Lawrence","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0021","first-page":"206","article-title":"Bullous lesion of larynx","volume":"5","author":"Belushi","year":"2015","journal-title":"An airway Emergency. Otolaryngol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0022","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/archderm.1990.01670330121028","article-title":"ory bullous pemphigoid leading to respiratory arrest and successfully treated with plasmapheresis","volume":"126","author":"Konstadt","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0023","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1365-2230.2008.03033.x","article-title":"Intravenous immunoglobulin treatment in laryngeal pemphigoid","volume":"34","author":"G\u00fcrcan","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0024","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-4362.1995.tb01095.x","article-title":"Cyclosporine therapy of life-threatening cicatricial pemphigoid affecting the respiratory tract","volume":"34","author":"Fanzca","year":"1995","journal-title":"Internatio J Dermatol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1600-0714.2011.01087.x","article-title":"Pharmacokinetics study about topical clobetasol on oral mucosa","volume":"41","author":"Varoni","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0026","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jdcr.2020.04.008","article-title":"Immunoglobulin M bullous pemphigoid: an enigma","volume":"6","author":"Baardman","year":"2020","journal-title":"JAAD Case Reports"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0027","first-page":"8","article-title":"Is there a linear IgM dermatosis? Significance of linear IgM junctional staining in cutaneous immunopathology","volume":"68","author":"Velthuis","year":"1988","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0028","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1365-2133.2004.06245.x","article-title":"Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients","volume":"151","author":"Mariotti","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0029","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(03)00035-5","article-title":"Cicatricial pemphigoid sera specifically react with the most C-terminal portion of BP180","volume":"32","author":"Lee","year":"2003","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0030","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1038\/sj.jid.5700465","article-title":"Antigen specificity in subsets of mucous membrane pemphigoid","volume":"126","author":"Rashid","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jvoice.2021.01.012_bib0031","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1046\/j.1523-1747.2002.19529.x","article-title":"Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain","volume":"119","author":"Hofmann","year":"2002","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199721000333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199721000333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:43:30Z","timestamp":1760211810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199721000333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0892199721000333"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2021.01.012","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laryngeal Pemphigoid Evolution and Response to Treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2021.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Voice Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}